HIV–Mycobacterium tuberculosis co‐infection: a ‘danger‐couple model’ of disease pathogenesis
Discussion on the mechanisms produced by infectious cofactors with impact on disease pathology could shed light on how to design potential interventions that could decelerate disease progression. With no vaccine for HIV and lack of an effective vaccine for tuberculosis, it is essential to design strategies against HIV–TB co‐infection.
Source: FEMS Immunology and Medical Microbiology - Category: Microbiology Authors: Esaki M. Shankar, Ramachandran Vignesh, Rada Ellegård, Muttiah Barathan, Yee K. Chong, M. Kahar Bador, Devi V. Rukumani, Negar S. Sabet, Adeeba Kamarulzaman, Vijayakumar Velu, Marie Larsson Tags: MiniReview Source Type: research
More News: Allergy & Immunology | Highly Active Antiretroviral Therapy | Men | Microbiology | Pathology | Study | Toxicology | Tuberculosis | Vaccines